Ping Lei
- Cancer Research top 5%
- Immunology top 5%
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 9
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 11
- Toxicology top 5%
- Oncology top 10%
- CAR-T cell therapy research 9
-
- Monoclonal and Polyclonal Antibodies Research 14
-
- Endoplasmic Reticulum Stress and Disease 9
-
- Vestibular and auditory disorders 9
Ping Lei
125 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 400
- Immunology 548
- Molecular Biology 1.3k
- Toxicology 55
- Oncology 435
Countries citing papers authored by Ping Lei
This map shows the geographic impact of Ping Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Lei more than expected).
Fields of papers citing papers by Ping Lei
This network shows the impact of papers produced by Ping Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Lei. The network helps show where Ping Lei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ping Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 25 | |
| 11 | 2016 | 7 | |
| 12 | 2016 | 33 | |
| 13 | 2012 | 23 | |
| 14 | 2012 | 14 | |
| 15 | 2009 | 24 | |
| 16 | 2009 | 9 | |
| 17 | 2008 | 15 | |
| 18 | 2008 | 7 | |
| 19 | 2007 | 22 | |
| 20 | Construction and Expression of Recombinant Gene for Fusion of Human Stem Cell Factor and EGFP | 2004 | 1 |
About Ping Lei
Ping Lei is a scholar working on Sensory Systems, Immunology, Neurology, Oncology and Physiology, having authored 132 papers that have together received 2.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), RNA Interference and Gene Delivery (11 papers), Immunotherapy and Immune Responses (10 papers), Endoplasmic Reticulum Stress and Disease (9 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (9 papers), Vestibular and auditory disorders (9 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Cancer Research (400 citations), Immunology (548 citations), Molecular Biology (1.3k citations), Toxicology (55 citations) and Oncology (435 citations). Ping Lei has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Stephen Safe, Indira Jutooru, Sudhakar Chintharlapalli, Gayathri Chadalapaka, Maen Abdelrahim, Huifen Zhu, Guanxin Shen, Zhenghao Wu, Zhenxiong Zhang and Zehua Lei. Their work appears in journals such as Frontiers in Immunology, Molecular Cancer Therapeutics, PLoS ONE, Acta Pharmacologica Sinica and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.